newsfilter
← Latest News
Business Wire·

Alzamend Neuro Announces Reverse Stock Split

Alzamend Neuro, Inc. (NASDAQ:ALZN) ("Alzamend" or the "Company"), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer's disease ("Alzheimer's"), bipolar